STAT5 Contributes to Interferon Resistance of Melanoma Cells
Open Access
- 20 September 2005
- journal article
- research article
- Published by Elsevier BV in Current Biology
- Vol. 15 (18), 1629-1639
- https://doi.org/10.1016/j.cub.2005.08.036
Abstract
No abstract availableFunding Information
- European Commission (FAIR PL 95-666)
- Deutsche Forschungsgemeinschaft (SFB 487)
This publication has 35 references indexed in Scilit:
- Pros and Cons of Adjuvant Interferon in the Treatment of MelanomaThe Oncologist, 2003
- The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell lineMelanoma Research, 2003
- Resistance to Interferons in Melanoma Cells Does Not Correlate with the Expression or Activation of Signal Transducer and Activator of Transcription 1 (Stat1)Journal of Interferon & Cytokine Research, 2002
- Interferon Signaling Is Dependent on Specific Tyrosines Located within the Intracellular Domain of IFNAR2cPublished by Elsevier BV ,2002
- Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in miceOncogene, 2000
- STATs in oncogenesisOncogene, 2000
- Distinct Mechanisms of STAT Phosphorylation via the Interferon-α/β ReceptorPublished by Elsevier BV ,2000
- Specific Activation of a STAT Family Member in Xiphophorus Melanoma CellsExperimental Cell Research, 1999
- Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanomaOncogene, 1999
- Cloning and Characterization of Novel CIS Family GenesBiochemical and Biophysical Research Communications, 1997